Individual sensititivy for the development of interstitial lung diseases (ILD)

Completed

• Conditions: chronic inflammatory lung diseases; lung fibrosis; sarcoidosis; 10038716

• Registration Number: NL-OMON33852
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

ILD diagnosis confirmed by lung biopsy, X ray or BALF analysis

Exclusion Criteria

smoking
pregnancy or lactation
use of vitamins or nutritional supplements

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>differences in the production of and the protection against ROS<br /><br>differences in the occurring inflammatory reaction</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>differences in the presence of so-called volatile organic compounds (VOCs) in<br /><br>the exhaled air</p><br>